| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34863-10ug | |||
| Carrier-Free | NBP2-34863-1mg | |||
| Carrier-Free | NBP2-34863-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75907SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75898SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12065-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35124-10ug | |||
| Carrier-Free | NBP2-35124-1mg | |||
| Carrier-Free | NBP2-35124-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35051-10ug | |||
| Carrier-Free | NBP2-35051-1mg | |||
| Carrier-Free | NBP2-35051-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35136-10ug | |||
| Carrier-Free | NBP2-35136-1mg | |||
| Carrier-Free | NBP2-35136-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35107-10ug | |||
| Carrier-Free | NBP2-35107-1mg | |||
| Carrier-Free | NBP2-35107-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52656-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81047-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81095-0.025mg | |||
![SDS-Page: Human IL-3 Protein [NBP2-34863]](http://images.novusbio.com/fullsize/Human-IL-3-Protein-SDS-Page-NBP2-34863-img0001.jpg "SDS-Page: Human IL-3 Protein [NBP2-34863]")
![Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-hu5c8-Ruplizumab-Western-Blot-NBP2-75907-img0001.jpg "Western Blot: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [NBP2-75907] - Rat spleen (lane 1), rat muscle (lane 2), rat bladder (lane 3), human breast tumour (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75907 at 1 ug/ml before being detected by a secondary antibody. The expected band size (29 kDa) is seen in the human-derived samples, as well as bands corresponding to dimers and other multimers.")
![Western Blot: TNF-alpha Antibody (cA2 (Infliximab)) - Chimeric [NBP2-75898] - Mouse liver (lane 1), mouse spinal cord (lane 2), mouse testis (lane 3), mouse colon (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75898 at 1.5 ug/ml before being detected by a secondary antibody. The expected band size (269 kDa) is seen in the human-derived samples, as well as a band corresponding to dimers.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-cA2-Infliximab-Chimeric-Western-Blot-NBP2-75898-img0002.jpg "Western Blot: TNF-alpha Antibody (cA2 (Infliximab)) - Chimeric [NBP2-75898] - Mouse liver (lane 1), mouse spinal cord (lane 2), mouse testis (lane 3), mouse colon (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75898 at 1.5 ug/ml before being detected by a secondary antibody. The expected band size (269 kDa) is seen in the human-derived samples, as well as a band corresponding to dimers.")
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (CAT-13.1E10) - Chimeric [NBP3-12065] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of CAT-13.1E10 (NBP3-12065) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12065, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD19-Antibody-CAT-13-1E10-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12065-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD19 Antibody (CAT-13.1E10) - Chimeric [NBP3-12065] - Immunofluorescence analysis of paraformaldehyde fixed human peripheral blood leukocytes on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of CAT-13.1E10 (NBP3-12065) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12065, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: CD19 Antibody (CAT-13.1E10) - Chimeric - Azide and BSA Free [NBP3-12065] - Paraformaldehyde fixed Daudi cells were stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-12065 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-12065_rabbit-monoclonal-cd19-antibody-cat-13-1e10-chimeric-74202522113010.png)
![SDS-Page: Mouse IL-33 Protein [NBP2-35124]](http://images.novusbio.com/fullsize/Mouse-IL-33-Protein-SDS-Page-NBP2-35124-img0001.jpg "SDS-Page: Mouse IL-33 Protein [NBP2-35124]")
![Functional: Human IL1 alpha Protein [NBP2-35051]](http://images.novusbio.com/fullsize/Human-IL1-alpha-Protein-Functional-NBP2-35051-img0001.jpg "Functional: Human IL1 alpha Protein [NBP2-35051]")
![SDS-Page: Human IL-1 alpha/IL-1F1 Protein [NBP2-35051]](http://images.novusbio.com/fullsize/Human-IL-1-alpha-IL-1F1-Protein-SDS-Page-NBP2-35051-img0002.jpg)
![SDS-Page: Mouse IL-7 Protein [NBP2-35136]](http://images.novusbio.com/fullsize/Mouse-IL-7-Protein-SDS-Page-NBP2-35136-img0001.jpg "SDS-Page: Mouse IL-7 Protein [NBP2-35136]")
![SDS-Page: Mouse IL-1 alpha/IL-1F1 Protein [NBP2-35107]](http://images.novusbio.com/fullsize/Mouse-IL-1-alpha-IL-1F1-Protein-SDS-Page-NBP2-35107-img0001.jpg "SDS-Page: Mouse IL-1 alpha/IL-1F1 Protein [NBP2-35107]")
![Western Blot: IL-2 Antibody (LNKB-2) [NBP2-81047] - Western Blot using anti-IL-2 antibody (LNKB-2) [NBP2-81047]. Untreated human peripheral blood monocyte (PBM) (A), PMA/lonomycin-treated PBM (B), human spleen (C), human thymus (D), Jurkat cell (E) and Molt4 cell (F) lysate samples (35ug protein in RIPA buffer) were resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of LNKB-2 [NBP2-81047] at 1 ug/ml (A, B) or 0.1 ug/ml (C-F) before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected running size for IL-2 is 17.6kDa. NBP2-81047 successfully detected Il-2 in multiple human tissue / cell samples.](http://images.novusbio.com/fullsize/IL-2-Antibody-LNKB-2-Western-Blot-NBP2-81047-img0001.jpg "Western Blot: IL-2 Antibody (LNKB-2) [NBP2-81047] - Western Blot using anti-IL-2 antibody (LNKB-2) [NBP2-81047]. Untreated human peripheral blood monocyte (PBM) (A), PMA/lonomycin-treated PBM (B), human spleen (C), human thymus (D), Jurkat cell (E) and Molt4 cell (F) lysate samples (35ug protein in RIPA buffer) were resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of LNKB-2 [NBP2-81047] at 1 ug/ml (A, B) or 0.1 ug/ml (C-F) before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected running size for IL-2 is 17.6kDa. NBP2-81047 successfully detected Il-2 in multiple human tissue / cell samples.")